Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
08 April 2021
Financial statements and reports, General meetings

Auditors’ report on 2020 Financial Statements in accordance with French Gaaps Open in new window

08 April 2021
Financial statements and reports, General meetings

2020 Universal Registration Document Open in new window

22 October 2020
Financial statements and reports, Regulated information

Amendment to the 2019 Universal Registration Document Open in new window

30 July 2020
Financial statements and reports

2020 Half-Year Financial Report Open in new window

08 April 2020
Financial statements and reports, Regulated information

2019 Universal Registration Document Open in new window

20 December 2019
Financial statements and reports, Regulated information

2018 Universal Registration Document Open in new window

24 July 2019
Financial statements and reports

2019 Half-Year Financial Report Open in new window

29 April 2019
Financial statements and reports

2018 Annual Financial Report Open in new window

25 July 2018
Financial statements and reports

2018 Half-Year Financial Report Open in new window

27 April 2018
Financial statements and reports

2017 Registration Document Open in new window

  • View previous 9 articles
  • 1
  • 2
  • 3
  • 4
  • View next 9 articles
© 2026 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page